Skip to main content

Advertisement

Log in

Effect of l-Arginine on Nitric Oxide Levels in Intrauterine Growth Restriction and its Correlation with Fetal Outcome

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

The current management of intrauterine growth restriction (IUGR) being empirical and aimed at selecting a safe time for delivery. Acknowledging the beneficial effects of l-arginine on endothelial vasculature the present study was designed to evaluate efficacy of l-arginine on bioavailability of nitric oxide (NO) with respect to fetal outcome. With l-arginine supplementation, mean NO levels were significantly increased and a significant mild reduction in systolic/end-diastolic velocity ratio (S/D ratio) was observed on doppler blood flow study, also neonatal outcome improved and incidences of complications were lowered. A deficiency in NO may play an important role in the causation of asymmetric fetal growth restriction. l-Arginine can be used to increase maternal NO levels, enhancing birth weight and decreasing neonatal morbidity. The ideal candidate for arginine therapy according to our study would be IUGR cases with S/D ratio less than 4.96 ± 0.49 and NO levels below 33 μmol/L with minimum of 3 weeks duration of arginine supplementation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Divon MY, Hsu HW. Maternal and fetal blood flow velocity waveforms in intrauterine growth retardation. Clin Obstet Gynecol. 1992;35:156–71.

    Article  CAS  PubMed  Google Scholar 

  2. Biswas R, Dasgupta A, Sinha RN, Chauduhri RN. An epidemiological study of low birth weight newborns in the district of Puruliya, West Bengal. Indian J Public Health. 2008;52(2):65–71.

    CAS  PubMed  Google Scholar 

  3. Gluckman PD, Hanson MA. The consequences of being born small: an adaptive perspective. Horm Res. 2006;65:5–14.

    Article  CAS  PubMed  Google Scholar 

  4. Mari G, Hanif F. Intrauterine growth restriction: how to manage and when to deliver. Clin Obstet Gynecol. 2007;50:497–509.

    Article  PubMed  Google Scholar 

  5. Sankaran S, Kyle PM. Aetiology and pathogenesis of IUGR. Best Pract Res Clin Obstet Gynaecol. 2009;23(6):765–77.

    Article  PubMed  Google Scholar 

  6. Kusinski LC, Stanley JL, Dilworth MR, Hirt CJ, Andersson IJ, Renshall LJ, et al. eNOS knockout mouse as a model of fetal growth restriction with an impaired uterine artery function and placental transport phenotype. Am J Physiol Regul Integr Comp Physiol. 2012;303(1):86–93.

    Article  Google Scholar 

  7. Lyall F, Greer IA, Young A, Myatt L. Nitric oxide concentrations are increased in fetoplacental circulation in intrauterine growth restriction. Placenta. 1996;17:165–8.

    Article  CAS  PubMed  Google Scholar 

  8. Redman CWG, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obs Gynecol. 1999;180:499–506.

    Article  CAS  Google Scholar 

  9. Resnik R. Intrauterine growth restriction. Obstet Gynecol. 2002;99:490–6.

    Article  PubMed  Google Scholar 

  10. Wu G, Bazer FW, Davis TA, Kim SW, Li P, MarcRhoads J, et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids. 2009;37:153–68.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J. 1998;336:1–17.

    CAS  PubMed Central  PubMed  Google Scholar 

  12. Wu G, Bazer FW, Wallace JM, Spencer TE. Board-invited review intrauterine growth retardation: implications for the animal sciences. J Anim Sci. 2006;84:2316–37.

    Article  CAS  PubMed  Google Scholar 

  13. Grisham MB, Johnson GG, Lancaster JR Jr. Quantitation of nitrite and nitrate in extra-cellular fluids. Methods Enzymol. 1996;268:237–46.

    CAS  PubMed  Google Scholar 

  14. Xu K, Dong M, Zhou J. Changes of maternal and umbilical serum nitric oxide in patients with the intrauterine growth retardation. Zhonghua Fu Chan Ke Za Zhi. 2000;35(12):715–6.

    CAS  PubMed  Google Scholar 

  15. Schiessl B, Strasburger C, Bidlingmaier M, Mylonas I, Jeschke U, Kainer F, et al. Plasma and urine concentrations of nitrite/nitrate and cyclic GMP in intrauterine growth restricted and preeclamptic pregnancies. Arch Gynecol Obstet. 2006;274:150–4.

    Article  CAS  PubMed  Google Scholar 

  16. Neri I, Mazza V, Galassi MC, Volpe A, Facchinetti F. Effects of L-arginine on utero-placental circulation in growth retarded fetuses. Acta Obstet Gynecol Scand. 1996;75:208–12.

    Article  CAS  PubMed  Google Scholar 

  17. Thureen PJ, Baron KA, Fennessey PV, Hay WW Jr. Ovine placental and fetal arginine and metabolism at normal and increased maternal plasma arginine concentrations. Peads Res. 2002;51:464–71.

    Article  CAS  Google Scholar 

  18. Montagnani M, Chen H, Barr VA, Quon MJ. Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser1179. J Biol Chem. 2001;276:30392–8.

    Article  CAS  PubMed  Google Scholar 

  19. Lakhkar BN, Rajagopal KN, Gaurishankar PT. Doppler prediction of adverse perinatal outcome in PIH and IUGR. Indian J Radiol Imag. 2006;16(1):109–16.

    Article  Google Scholar 

  20. Roy A, Mukherjee S, Bhattacharyya SK, Banerjee P, Das B, Patra KK. Perinatal outcome in pregnancies with intra-uterine growth restriction by using umbilical and middle cerebral artery colour Doppler. J Indian Med Assoc. 2012;110(3):154–7.

    PubMed  Google Scholar 

  21. Xiao XM, Li LP. L-arginine treatment for asymmetric fetal growth restriction. Int J Gynecol Obstet. 2005;88(1):15–8.

    Article  CAS  Google Scholar 

  22. Lampariello C, De Blasio A, Merenda A, Graziano E, Michalopoulou A, Bruno P. Use of L-arginine in intrauterine growth retardation (IUGR): authors’ experience. Minerva Ginecol. 1997;49:577–81.

    CAS  PubMed  Google Scholar 

  23. Winer N, Branger B, Azria E, Tsatsaris V, Philippe HJ, Rozé JC, et al. L-arginine treatment for severe vascular fetal intrauterine growth restriction: a randomized double-bind controlled trial. Clin Nutr. 2009;28(3):243–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Archana Singh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, S., Singh, A., Sharma, D. et al. Effect of l-Arginine on Nitric Oxide Levels in Intrauterine Growth Restriction and its Correlation with Fetal Outcome. Ind J Clin Biochem 30, 298–304 (2015). https://doi.org/10.1007/s12291-014-0450-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-014-0450-4

Keywords

Navigation